Wechat

Website

Chinese Journal of Oncology Prevention and Treatment ›› 2019, Vol. 11 ›› Issue (6): 485-491.doi: 10.3969/j.issn.1674-5671.2019.06.07

Previous Articles     Next Articles

Effect of ellagic acid on the biological behaviors of BRCA1  silenced triple negative breast cancer cell line MDA-MB-231 and its possible machanism

  

  • Online:2019-12-25 Published:2020-01-19

Abstract: Objective To investigate the effects of ellagic acid(EA) on the biological behaviors of breast cancer susceptibility gene 1(BRCA1) silenced in triple negative breast cancer cell line MDA-MB-231 and its possible mechanism. Methods Different concentrations of EA (0 μg/mL,1 μg/mL, 5 μg/mL,10 μg/mL and 20 μg/mL) were used to treat MDA-MB-231 cells for 24 h,48 h and 72 h,respectively. The inhibition rate of proliferation were assessed by MTT assay and the IC50 was calculated to select the optimal drug concentration. After transfecting BRCA1 siRNA into MDA-MB-231 cells,EA was applied at a final concentration of 5 μg/mL for 0 h,24 h,48 h,72 h,96 h,and cell proliferation was detected by MTT assay. Scratch assay was used to detect cell migration,Transwell chamber was used to detect cell migration and invasion,RT-qPCR and Western blot were used to detect the expression of PARP1 mRNA and protein. Results Different concentrations of EA had significant inhibitory effect on the proliferation of MDA-MB-231 cells at 24 h,48 h and 72 h,and IC50 were 13.739 μg/mL,10.645 μg/mL,5.344 μg/mL,respectively. The OD value in siRNA+EA group was significantly lower than that of control group,EA group and negative control group(P<0.001). The cell migration rate and the number of transmembrane cells in siRNA+EA group were lower than those of the other three groups(P<0.001),and the expression of PARP1 mRNA and protein in siRNA+EA group were also significantly lower than those of the other three groups(P<0.001). Conclusions EA can inhibit the proliferation,migration and invasion of BRCA1 silenced MDA-MB-231 cells in vitro,and its mechanism may be related to related DNA repair pathway disorders.

Key words: Triple negative breast cancer, Ellagic acid, BRCA1, PARP1, MDA-MB-231 cell

CLC Number: 

  • R737.9